Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Microfluidics Research Report 2026-2035: A $20.73 Billion Market by 2030 with Thermo Fisher Scientific, PerkinElmer, Dolomite, Agilent Technologies, Bio-Rad Laboratories, and Fluidigm Leading

globenewswire.com
TMO Mentioned as a key player leading the microfluidics market growth, which is projected to reach $20.73 billion by 2030. The article does not provide specific positive or negative news about the company itself. BIO Included as a key company in the microfluidics sector. The report discusses the overall market's positive trajectory and innovation, but lacks specific commentary on Bio-Rad Laboratories' individual performance or prospects.

Dublin, Feb. 23, 2026 (GLOBE NEWSWIRE) -- The "Microfluidics Market Report 2026" has been added to ResearchAndMarkets.com's offering.

The microfluidics market is poised for significant growth, projected to surge from $10.33 billion in 2025 to $11.89 billion in 2026 with a CAGR of 15%, and further expected to reach $20.73 billion by 2030. This growth is driven by increased lab-on-a-chip research, demand for miniaturized diagnostics, pharmaceutical R&D adoption, and expansion in clinical testing and device advancements.

Key developments include the adoption of microfluidics in point-of-care diagnostics, personalized medicine, polymer-based microfluidics, and high-throughput screening integrated with IoT and smart labs. Notable trends foresee microfluidics intertwining with drug delivery, clinical diagnostics, industrial solutions, and precision fluid manipulation technologies.

Clinical studies on cell-based therapies have underscored the utility of microfluidics, notably advancing biomanufacturing for drug, gene, and cell therapies. In July 2023, the American Society of Gene and Cell Therapy reported a 58% increase in non-oncology gene therapy trials, highlighting microfluidics' role in this domain.

Major players are innovating with lab-on-a-chip devices to enhance diagnostic accuracy and reduce processing times. An exemplar is Takara Bio's launch of a dissolvable microfluidic lentiviral transduction enhancer in March 2024, offering improved gene delivery for therapy applications and simplifying experimental setups.

Corporate activities reflect the sector's dynamism. In January 2025, bioMerieux acquired SpinChip Diagnostics ASA for USD 0.15 billion, aiming to expand its microfluidics-driven diagnostic capabilities leveraging SpinChip's advanced technology for rapid, sensitive testing.

Notable companies shaping the market include Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, and Fluidigm Corporation, among others. North America emerges as both the largest and fastest-growing region, with significant contributions also expected from Asia-Pacific and Europe.

The market's scope encompasses molecular sensors, DNA analysis, cell separation, and more, driven by direct sales and services offered to consumers. The revenue figures reflect consumption values within designated geographies, covering a range of regions like Australia, China, France, India, Japan, the UK, and the USA.

Report Scope:

Markets Covered:

Subsegments:

Key Companies Mentioned: Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, Fluidigm Corporation, Dolomite Microfluidics, PerkinElmer, Inc., Sphere Fluidics Limited, among others.

Key Attributes:

Key Technologies & Future Trends

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/8u34k2

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment